EP2931298 - FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN, FORMULATION AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.06.2017 Database last updated on 22.08.2024 | |
Former | Request for examination was made Status updated on 12.02.2017 | Most recent event Tooltip | 30.06.2017 | Application deemed to be withdrawn | published on 02.08.2017 [2017/31] | Applicant(s) | For all designated states Teva Pharmaceutical Industries Ltd. 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL | [N/P] |
Former [2015/43] | For all designated states Teva Pharmaceutical Industries Ltd. 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL | Inventor(s) | 01 /
BROWN, Kurt 634 Moreno Road Narberth, PA 19072 / US | 02 /
BASSAN, Merav 15a Ziporen Street Netanya / IL | [2015/43] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2015/43] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 13861675.0 | 10.12.2013 | [2015/43] | WO2013US74145 | Priority number, date | US201261736267P | 12.12.2012 Original published format: US 201261736267 P | [2015/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014093354 | Date: | 19.06.2014 | Language: | EN | [2014/25] | Type: | A1 Application with search report | No.: | EP2931298 | Date: | 21.10.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.06.2014 takes the place of the publication of the European patent application. | [2015/43] | Search report(s) | International search report - published on: | US | 19.06.2014 | (Supplementary) European search report - dispatched on: | EP | 08.06.2016 | Classification | IPC: | A61K38/00, C12P21/04, A61P5/02 | [2016/27] | CPC: |
A61K38/27 (EP,US);
A61P5/02 (EP);
A61P5/06 (EP)
| C-Set: |
A61K38/27, A61K2300/00 (EP,US)
|
Former IPC [2015/43] | A61K38/00, C12P21/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/43] | Extension states | BA | 09.07.2015 | ME | 09.07.2015 | Title | German: | FUSION VON MENSCHLICHEN WACHSTUMSHORMONEN UND ALBUMIN SOWIE FORMULIERUNG DARAUS UND VERWENDUNG DAVON | [2015/43] | English: | FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN, FORMULATION AND USES THEREOF | [2015/43] | French: | FUSION D'HORMONE DE CROISSANCE HUMAINE ET D'ALBUMINE, SA FORMULATION ET SES UTILISATIONS | [2015/43] | Entry into regional phase | 09.07.2015 | National basic fee paid | 09.07.2015 | Search fee paid | 09.07.2015 | Designation fee(s) paid | 09.07.2015 | Examination fee paid | Examination procedure | 09.07.2015 | Amendment by applicant (claims and/or description) | 09.07.2015 | Examination requested [2015/43] | 05.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/31] | 13.02.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/31] | Fees paid | Renewal fee | 22.12.2015 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.12.2016 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2002155990 (FOSTER MICHAEL B [US]) [A] 15 * the whole document *; | [A]US2002156019 (FOSTER MICHAEL B [US]) [A] 15 * the whole document *; | [Y]WO03060071 (HUMAN GENOME SCIENCES INC [US], et al) [Y] 15 * page 5, paragraph 7 * * page 455, paragraph 1238 - page 461, paragraph 1262 * * paragraph [0251] *; | [Y]WO2011029892 (HOFFMANN LA ROCHE [CH], et al) [Y] 15 * page 1, paragraph 26; claim 7 *; | [Y] - WILCOX ANGELA M, "Characterization of albutropin fusion protein: A novel, long-acting form of human growth hormone", AMERICAN CHEMICAL SOCIETY. ABSTRACTS OF PAPERS (AT THE NATIONAL MEETING), AMERICAN CHEMICAL SOCIETY, US, (20030101), vol. 225, no. 1-2, ISSN 0065-7727, page BIOT10, XP009157330 [Y] 15 * the whole document * | [Y] - OSBORN B L ET AL, "Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, (20021205), vol. 456, no. 1-3, doi:10.1016/S0014-2999(02)02644-4, ISSN 0014-2999, pages 149 - 158, XP002339364 [Y] 15 * the whole document * DOI: http://dx.doi.org/10.1016/S0014-2999(02)02644-4 | [Y] - Eva Y Chi, "Excipients and their Effects on the Quality of Biologics", (20120414), pages 1 - 9, URL: https://www.aaps.org/uploadedFiles/Content/Sections_and_Groups/Sections/Formulation_Design_And_Development_Section/FDDTechCornerMay2012.pdf, (20160519), XP002757831 [Y] 15 * page 3, paragraph 4 * | [A] - "CONSENSUS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ADULTS WITHGROWTH HORMONE DEFICIENCY: SUMMARY STATEMENT OF THE GROWTH HORMONE RESEARCH SOCIETY WORKSHOP ON ADULT GROWTH HORMONE DEFICIENCY", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (19880201), vol. 83, no. 2, doi:10.1210/JC.83.2.379, ISSN 0021-972X, pages 379 - 381, XP000990269 [A] 15 * the whole document * DOI: http://dx.doi.org/10.1210/jc.83.2.379 | [T] - ORIT COHEN-BARAK ET AL, "Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency", EUROPEAN JOURNAL OF ENDOCRINOLOGY, GB, (20151128), vol. 173, no. 5, doi:10.1530/EJE-15-0554, ISSN 0804-4643, pages 541 - 551, XP055273213 [T] 15 DOI: http://dx.doi.org/10.1530/EJE-15-0554 | International search | [Y]WO2011029892 (HOFFMANN LA ROCHE [CH], et al); | [Y]US8108149 (CLARK ROSS GRAHAM [NZ], et al); | [X]US8211439 (ROSEN CRAIG A [US], et al); | [Y] - KEMP, SF ET AL., "Pharmacokinetic And Pharmacodynamic Characteristics Of A Long-Acting Growth Hormone Preparation (Nutrpin Depot) In GH-Deficient Children.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, (20040701), vol. 89, no. 7, pages 3234 - 3240, XP055185639 DOI: http://dx.doi.org/10.1210/jc.2003-030825 |